Inovio Pharmaceuticals
Clinical trials sponsored by Inovio Pharmaceuticals, explained in plain language.
-
MERS vaccine shows promise in phase 2 trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called INO-4700 to prevent MERS, a serious respiratory virus. It involved 192 healthy adults who received either the vaccine or a placebo. The goal was to check if the vaccine is safe and triggers an immune response. The vaccine was given as a shot…
Phase: PHASE2 • Sponsor: Inovio Pharmaceuticals • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:56 UTC
-
DNA vaccine shows promise in reducing surgeries for rare throat tumor condition
Disease control CompletedThis study tested a new treatment called INO-3107 for people with recurrent respiratory papillomatosis (RRP), a rare condition where non-cancerous tumors grow in the airway due to HPV-6 or HPV-11. The treatment is a DNA vaccine given with a small electrical pulse to help it enter…
Phase: PHASE1, PHASE2 • Sponsor: Inovio Pharmaceuticals • Aim: Disease control
Last updated May 18, 2026 12:03 UTC